W.H. Cornerstone Investments Inc. Sells 42 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

W.H. Cornerstone Investments Inc. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,195 shares of the healthcare conglomerate’s stock after selling 42 shares during the period. W.H. Cornerstone Investments Inc.’s holdings in UnitedHealth Group were worth $604,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. AMF Tjanstepension AB increased its holdings in UnitedHealth Group by 88.0% during the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after buying an additional 121,180 shares during the last quarter. Hudson Value Partners LLC raised its stake in UnitedHealth Group by 8.3% in the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after acquiring an additional 82 shares during the period. Wealth Group Ltd. boosted its position in UnitedHealth Group by 4.0% during the third quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock worth $1,039,000 after purchasing an additional 68 shares during the period. Creative Planning raised its holdings in UnitedHealth Group by 11.0% in the 3rd quarter. Creative Planning now owns 212,295 shares of the healthcare conglomerate’s stock valued at $123,025,000 after acquiring an additional 21,114 shares during the period. Finally, Leisure Capital Management lifted its holdings in UnitedHealth Group by 4.3% during the 3rd quarter. Leisure Capital Management now owns 2,932 shares of the healthcare conglomerate’s stock worth $1,714,000 after purchasing an additional 121 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on UNH. Wells Fargo & Company cut their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Piper Sandler decreased their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Barclays decreased their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Finally, Truist Financial cut their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $629.32.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.33% of the stock is owned by insiders.

UnitedHealth Group Stock Up 0.7 %

Shares of UnitedHealth Group stock opened at $531.31 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a 50-day moving average of $524.58 and a 200 day moving average of $563.71. The firm has a market cap of $488.96 billion, a price-to-earnings ratio of 34.28, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the business posted $5.83 EPS. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.